Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Investing Cash Flow
Net cash used in or generated by investments in assets, acquisitions, and securities.
Investing Cash Flow history
Currency unavailable · from the cash flow
No Investing Cash Flow data reported for this period type.
Investing Cash Flow vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
ORKAOruka Therapeutics, Inc. | LTM Sep 2026 | $606.81M USD | +49.9% | +3543.6% | — |
| LTM Sep 2026 | $492.54M USD | +639.4% | — | 544.3% | |
| LTM Mar 2026 | $248.17M USD | +496.1% | — | 106.8% | |
ALMSAlumis Inc. Common Stock | LTM Jun 2026 | $97.94M USD | -191.9% | — | 1323.9% |
| LTM Jun 2026 | $78.72M USD | +130.6% | — | 27.9% | |
| LTM Mar 2026 | $1.69M USD | -97.5% | +56.5% | 20.2% | |
| LTM Mar 2026 | $116K USD | -58.6% | -74.5% | — | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | — | — | — | — | — |
| Peer median (excluding ODTX) | — | +49.9% | +56.5% | 106.8% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.